Society for Endocrinology - a world-leading authority on hormones

Corporate Supporters

HRA Pharma

HRA Pharma has been a significant presence in the niche area of adrenal cortical carcinoma since 2004, providing a standard therapy for this serious condition and a free of charge drug monitoring service to support clinicians in optimising its use.

HRA Pharma has more recently become a significant player in the field of Cushing’s syndrome investing in two well-established but key treatment entities to further enhance its standing in the endocrine arena.

For more information on HRA Pharma, visit


Partnership level

Platinum members

Gold members

Silver members